2023

1. Local delivery of optimized nanobodies targeting the PD-1/PD-L1 axis with a self-amplifying RNA viral vector induces potent antitumor responses

   Cancer Letters, Vol. 561

2. Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

   Nature Medicine, Vol. 29, Núm. 3, pp. 632-645